Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alexion Pharmaceuticals
Biotech
AstraZeneca’s Alexion pens $825M AAV capsid pact with JCR
AstraZeneca’s rare disease unit Alexion has penned a $825 million deal for AAV capsids from existing partner JCR Pharmaceuticals.
James Waldron
Jul 9, 2025 4:52am
AstraZeneca's Alexion hopes to extend dominance in PNH
Dec 16, 2022 7:25am
AstraZeneca's Alexion, Arvinas nab space at new biotech tower
Apr 15, 2022 9:40am
Stealth rare disease drug denied by FDA in I told you so moment
Oct 20, 2021 9:30am
AstraZeneca’s Alexion taps Genomenon for rare disease work
Sep 20, 2021 10:46am
Alexion alums land at complement biotech Kira Pharma
Feb 23, 2021 11:17am
